Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CANBRIDGE-PHARMACEUTICALS-130070920/news/CANbridge-Pharmaceuticals-Announces-CAN008-Phase-1-2-Glioblastoma-Multiforme-Abstract-Accepted-by-th-43242056/?utm_source=whatsapp&utm_medium=social&utm_campaign=share